[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100310030":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":25,"locations":25,"responsibleParty":32,"collaborators":25,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":25,"eligibilityCriteria":41,"healthyVolunteers":37,"sex":42,"minAge":43,"maxAge":44,"enrollmentInfo":45,"targetDuration":25,"studyType":48,"phases":49,"briefSummary":51,"conditions":52,"keywords":54,"overallStatus":57,"whyStopped":58,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":65,"locationsCount":25},{"fullName":5,"class":6},"Maisonneuve-Rosemont Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 5","EXPERIMENTAL","stellate ganglion block with ropivacaine 0.2% 5 mL",[13],"Procedure: stellate ganglion block with ropivacaine 0.2% 5 mL",{"label":15,"type":16,"description":17,"interventionNames":18},"Group 2","ACTIVE_COMPARATOR","stellate ganglion block wit ropivacaine 0.2% 2 mL",[19],"Procedure: stellate ganglion block wit ropivacaine 0.2% 2 mL",[21,26],{"type":22,"name":11,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","Each patient will undergo two stellate ganglion blocks and receive both volumes of local anesthetics in random order. The stellate ganglion blocks will be separated by 3 weeks in order to assure that no residual effects from the previous block will influence the results.",[9],null,{"type":22,"name":17,"description":23,"armGroupLabels":27,"otherNames":25},[15],[29],{"name":30,"affiliation":5,"role":31},"Veronique Brulotte, MD","PRINCIPAL_INVESTIGATOR",{"type":31,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Veronique Brulotte","MD, MSc, FRCPC","100310030","comparison-of-volumes-of-local-anesthetics-on-the-efficiency-and-safety-of-stellate-ganglion-block-for-crps-of-the-arm-100310030",false,"NCT03316066","Comparison of Volumes of Local Anesthetics on the Efficiency and Safety of Stellate Ganglion Block for CRPS of the Arm","Comparison of Two Volumes of Local Anesthetics on the Efficiency and Safety of Stellate Ganglion Block for the Treatment of Complex Regional Pain Syndrome of the Arm","Inclusion Criteria:\n\n* Patients with a diagnosis of complex regional pain syndrome of the arm according to the Budapest criteria and having already received a minimum of 3 stellate ganglion blocks. Only patients having received a minimum of 3 stellate ganglion blocks will be included since it is expected to have a progressive and sustained decrease in pain scores during the first 3 blocks.\n* ASA 1 to 3 included\n\nExclusion Criteria:\n\n* Patient refusal\n* Contra-indications to the stellate ganglion block procedure such as coagulopathy, anticoagulants or anti platelet therapy other than aspirin, systemic or injection site infection, important neck deformity (post-radiotherapy or surgery, etc.), severe chronic obstructive pulmonary disease, contralateral diaphragm paralysis or contralateral pneumonectomy\n* Allergy to local anesthetics\n* Concomitant pain syndrome other than complex regional pain syndrome of the arm\n* Liver or kidney failure (CrCl \\\u003C 30 ml\u002Fmin)\n* Inability to understand à verbal numeric pain score scale after careful explanations\n* Inability to consent","ALL","18 Years","80 Years",{"count":46,"type":47},0,"ACTUAL","INTERVENTIONAL",[50],"NA","The purpose of this study is to compare the efficiency and safety of 2ml versus 5ml of local anesthetics used in stellate ganglion blocks for the treatment of complex regional pain syndrome of the arm.",[53],"Complex Regional Pain Syndromes",[55,56],"Stellate Ganglion","Local Anesthetic","WITHDRAWN","Not able to recruit enough patients","2020-02-21",{"date":61,"type":47},"2020-02-24",{"date":63,"type":47},"2018-10-20",{"date":59,"type":47},{"name":5,"class":6}]